New Drug Molnupiravir Get DCGI Approval, Can It Be the Solution for the Fight Against COVID-19

The Drug Controller General of India (DCGI) has given its nod to Molnupiravir for Emergency Use Authorisation (EUA) for the treatment of adult patients with Covid-19 and who have high risk of progression of the disease.

Related Keywords

India , ,Drug Controller General ,Emergency Use Authorisation ,Molnupiravir ,Drug ,Covid 19 ,Cgi Approval ,Micron ,Ovid 19 Cases ,Omicron Variant ,Ars Cov 2 ,Ovid 19 Infection ,Delta Variant ,Scientists ,Covid 19 Treatment ,Drug Controller General Of India ,Ua ,Nti Viral Oral Pill ,Harmaceutical Giant Merck Co ,Medicines And Healthcare Products Regulatory Agency ,Phra ,Us Food And Drug Administration ,Fda ,Antimicrobial Drugs Advisory Committee ,Gmdac ,Pp Bose ,Ational Heart Institute And Fortis Cdoc ,Cipla ,